Benjamin Elison Gewurz

Top grants by award amount

Benjamin Elison Gewurz's NIH grant portfolio, ranked by award amount.

• 5U01CA275301-03U01

  B cell determinants of EBV latency

  Weill Cornell Medicine
  $827.3K

  award amount
• 1R01DE033907-01R01

  Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling

  Brigham and Women's Hospital
  $528.2K

  award amount
• 5R01AI164709-04R01

  Regulation of the Epstein-Barr Virus Lytic Switch

  Brigham and Women's Hospital
  $505.7K

  award amount
• 5R21AI170751-02R21

  Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway

  Brigham and Women's Hospital
  $268.5K

  award amount
• 1R21AI181873-01A1R21

  Systematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell Lysis

  Brigham and Women's Hospital
  $223.8K

  award amount
• 5P01CA269043-02P01

  Targeting the Epigenetic and Metabolic Control of EBV-Epithelial Cancers

  Wistar Institute
  $200.2K

  award amount
• 1R13CA294854-01R13

  Epstein-Barr Virus/Kaposi Sarcoma Associated Herpesvirus 2024 Meeting

  Brigham and Women's Hospital
  $20.3K

  award amount

Affiliations

Institutions that have administered grants for Benjamin Elison Gewurz.

Career milestones

Key NIH funding milestones over time.

1. 2024
   First NIH Award
   Brigham and Women's Hospital
2. 2024
   $500K Cumulative Funding
3. 2024
   $1M Cumulative Funding
4. 2024
   $2M Cumulative Funding
5. 2024
   Entered Top 50% Nationally
   Ranked #3444
6. 2024
   Entered Top 25% Nationally
   Ranked #3444
7. 2024
   Multi-Institutional Research
   Awards at 3 institutions

Related investigators

Other NIH-funded PIs frequently associated with Benjamin Elison Gewurz.